Literature DB >> 21605911

Are "social drugs" (tobacco, coffee and chocolate) related to the bipolar spectrum?

Icro Maremmani1, Giulio Perugi, Luca Rovai, Angelo Giovanni Icro Maremmani, Matteo Pacini, Pier Luigi Canonico, Paolo Carbonato, Claudio Mencacci, Giovanni Muscettola, Luca Pani, Riccardo Torta, Claudio Vampini, Hagop S Akiskal.   

Abstract

BACKGROUND: Across all ages and cultures, mankind has always used substances in order to induce pleasurable sensations or desirable psychophysical states. These substances, notably caffeine, tobacco, alcohol and chocolate, can be labeled 'social drugs'.
METHODS: We analyzed the social drug habits of 562 patients suffering from mood disorders, according to DSM-IV-R criteria (major depressive episode, recurrent depression, bipolar type I and II disorders and depression not otherwise specified). The sample was also divided into bipolar and non-bipolar according to Hypomania Check-list 32 (HCL-32), which proposes a broader concept of hypomania and soft bipolarity, comprising the spectrum of bipolar disorders proper, along with other, "softer" expressions of bipolarity intermediate between bipolar disorder and normality.
RESULTS: Using HCL-32 criteria, but DSM-IV-R criteria, a link was confirmed between bipolar spectrum and substance use including social drugs such as tobacco and coffee. LIMITATION: Observational correlational study.
CONCLUSION: This study is in support of earlier theoretical formulations within the framework of the Pisa-San Diego collaboration.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605911     DOI: 10.1016/j.jad.2011.04.019

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  3 in total

1.  Manic Episode Following Ingestion of Caffeine Pills: A Case Report.

Authors:  Boris M Kiselev; Shady S Shebak; Thomas R Milam
Journal:  Prim Care Companion CNS Disord       Date:  2015-06-25

2.  Increased tobacco and alcohol use among women with joint hypermobility: a way to cope with anxiety?

Authors:  C Baeza-Velasco; A Stoebner-Delbarre; F Cousson-Gélie; G Pailhez; A Bulbena; F Baguet; M C Gély-Nargeot
Journal:  Rheumatol Int       Date:  2014-05-30       Impact factor: 2.631

3.  Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study.

Authors:  Angelo Giovanni Icro Maremmani; Silvia Bacciardi; Luca Rovai; Fabio Rugani; Enrico Massimetti; Denise Gazzarrini; Liliana Dell'Osso; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2014-12-12       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.